Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse

Prof David Marks - University Hospital Bristol, Bristol, UK
Issues in allogeneic HSCT: Therapeutic options for post-transplant relapse ( Prof David Marks - University Hospital Bristol, Bristol, UK )
24 May 2019

CNS involvement and prophylaxis in acute lymphoblastic leukaemia

Dr Mark Litzow - Mayo Clinic, Rochester, USA
CNS involvement and prophylaxis in acute lymphoblastic leukaemia ( Dr Mark Litzow - Mayo Clinic, Rochester, USA )
24 May 2019

Indications for allogeneic haematopoietic stem cell transplantation in adult acute lymphoblastic leukaemia

Dr Mark Litzow - Mayo Clinic, Rochester, USA
Indications for allogeneic haematopoietic stem cell transplantation in adult acute lymphoblastic leukaemia ( Dr Mark Litzow - Mayo Clinic, Rochester, USA )
24 May 2019

Metabolic vulnerability in NOTCH-driven T cell acute lymphoblastic leukaemia

Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK
Metabolic vulnerability in NOTCH-driven T cell acute lymphoblastic leukaemia ( Dr Etienne De Braekeleer - Wellcome Sanger Institute, Cambridge, UK )
24 May 2019

MLL-rearranged acute lymphoblastic leukaemia

Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain
MLL-rearranged acute lymphoblastic leukaemia ( Dr Pablo Menéndez - Josep Carreras Leukemia Research Institute, Barcelona, Spain )
24 May 2019

Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphoblastic leukaemia

Prof Max Topp - University of Würzburg, Würzburg, Germany
Updates on bispecific T cell engagers (BiTEs) for the treatment of acute lymphoblastic leukaemia ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
24 May 2019

MRD management in adults with acute lymphoblastic leukaemia

Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy
MRD management in adults with acute lymphoblastic leukaemia ( Dr Renato Bassan - Ospedale dell'Angelo & Ospedale SS, Venice, Italy )
24 May 2019

Using CAR T cells for the treatment of acute lymphoblastic leukaemia

Prof Claudia Rossig - Universität Münster, Münster, Germany
Using CAR T cells for the treatment of acute lymphoblastic leukaemia ( Prof Claudia Rossig - Universität Münster, Münster, Germany )
24 May 2019

Optimal use of tyrosine kinase inhibitors as a treatment for Philadelphia chromosome-positive acute lymphoblastic leukaemia

Prof Hervé Dombret, University Paris Diderot, Paris, France
Optimal use of tyrosine kinase inhibitors as a treatment for Philadelphia chromosome-positive acute lymphoblastic leukaemia ( Prof Hervé Dombret, University Paris Diderot, Paris, France )
24 May 2019

Highlights from ICALL 2019

Prof Hervé Dombret - University Paris Diderot, Paris, France
Highlights from ICALL 2019 ( Prof Hervé Dombret - University Paris Diderot, Paris, France )
24 May 2019

Precision diagnosis for tailored therapy in acute lymphoblastic leukaemia

Dr Jean-Pierre Bourquin - University Children’s Hospital, Zurich, Switzerland
Precision diagnosis for tailored therapy in acute lymphoblastic leukaemia ( Dr Jean-Pierre Bourquin - University Children’s Hospital, Zurich, Switzerland )
24 May 2019

Integrating, balancing and disregarding risk factors in paediatric acute lymphoblastic leukaemia

Prof Anthony Moorman - Newcastle University, Newcastle, UK
Integrating, balancing and disregarding risk factors in paediatric acute lymphoblastic leukaemia ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )
24 May 2019